Research
Adherence
Personalized glycemic targets should be less aggressive in older patients or those with reduced life expectancy to minimize hypoglycemia risk and polypharmacy burden.
If you are older or have other serious health conditions, your doctor may aim for a higher blood sugar target to keep you safe from dangerous lows and side effects. This focuses on your quality of life rather than just a number.
GoodQualifiesHIGH confidence
In patients with older age or reduced life expectancy, a personalized glycemic target acceptable to the patient and clinician to minimize the risk of harm should be agreed. Consensus guidelines advocate less aggressive glycemic targets in people with T2D in this patient group.
Why this rating
Cites consensus guidelines and general stance.
Source
Personalized Type 2 Diabetes Management: An Update on Recent Advances and Recommendations
David M. Williams et al. · Dove Medical Press (Taylor and Francis Group) · 2022
narrative_reviewCited 102×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →